πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8440206

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440202

Induction of an immune response against dengue virus using the prime-boost approach

United States of America as represented by the Secretary of the Air Force Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435979

Use of imipramine blue and analogs thereof in treating cancers

The United States of America as Represented by the Dept. of Veterans Affairs Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8435507

Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccin

The United States of America as Represented by the Dept. of Veterans Affairs Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431690

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431134

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathoge

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8431176

Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

The United States of America as represented by the Secretary of the Army Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426575

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and no

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426574

Identification of astrovirus VA1 associated with gastroenteritis in humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426445

Iminosugars and methods of treating bunyaviral and togaviral diseases

United Therapeutics Corporation Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8426379

POT1 alternative splicing variants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420664

A3 adenosine receptor allosteric modulators

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420620

Induced internalization of surface receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420607

Anthrax carbohydrates, synthesis and uses thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420107

Peptide vaccines against group A streptococci

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420099

Chimeric protein for prevention and treatment of HIV infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8420072

Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an ina

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8415456

Substituted IL-15 polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8415097

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8410292

Epoxy-guaiane derivatives and treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8410169

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8410063

N-acetyl mannosamine as a therapeutic agent

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8409858

Modular functional peptides for the intracellular delivery of nanoparticles

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8409585

Method for increasing performance of offspring

JBS UNITED, INC. Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted